The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

ABSTRACT:

Background

Managed entry agreements (MEAs) are a set of instruments to facilitate access to new medicines. This study surveyed the implementation of MEAs in Central and Eastern Europe (CEE) where limited comparative information is currently available.

Method

We conducted a survey on the implementation of MEAs in CEE between January and March 2017.

Results

Sixteen countries participated in this study. Across five countries with available data on the number of different MEA instruments implemented, the most common MEAs implemented were confidential discounts (n = 495, 73%), followed by paybacks (n = 92, 14%), price-volume agreements (n = 37, 5%), free doses (n = 25, 4%), bundle and other agreements (n = 19, 3%), and payment by result (n = 10, >1%). Across seven countrie

SUBMITTER: Ferrario A 

PROVIDER: S-EPMC5684278 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature